Latest Asx News

Insignia Financial Ltd shareholders are invited to vote on a $4.80 per share acquisition scheme by Daintree BidCo, an entity backed by CC Capital Partners LLC and affiliates. The Federal Court has approved the Scheme Meeting and the distribution of the Scheme Booklet, which includes an Independent Expert’s Report supporting the fairness and reasonableness of the offer.

Thorney Opportunities Ltd has returned to profitability with a $6.55 million net profit for the half-year ending December 2025, declaring a fully franked interim dividend and continuing its share buy-back program.

Skin Elements Limited reported a $4.01 million loss for the half-year ending December 2025, alongside a 41% revenue drop, while securing $2.5 million in fresh capital to advance its proprietary SE Formula biotechnology products.

Clime Investment Management reports a strong half-year operating profit surge and proposes a fully franked interim dividend, while streamlining its business to target sophisticated investors.

Verbrec Limited has reported a remarkable turnaround in its half-year results, posting a $9 million net profit and announcing its first interim dividend in the current period. Strategic acquisitions and a sharp rise in net tangible assets underpin this strong performance.

Radiopharm Theranostics reported a 44% increase in net loss to $27 million for the half-year ended December 2025, driven by expanded R&D spending. The company bolstered its cash reserves through a $35 million placement while progressing multiple clinical trials across its radiopharmaceutical pipeline.

Senetas Corporation reported a reduced half-year loss with stable revenue, despite export permit delays in the Middle East. The company’s strategic alliance with Nokia and ongoing sovereign encryption developments underpin a positive outlook for FY2026.

Energy Technologies Limited reported a $5.63 million net loss for the half-year ending December 2025, with revenue down 53% as the company restructures and refocuses on renewable energy markets. Significant debt refinancing and board changes mark a critical phase for the industrial cable manufacturer.

Racura Oncology reported a $4.1 million loss for H1 FY26, reflecting heavy investment in clinical trials and intellectual property. The company also boosted cash reserves through capital raises and rebranded from Race Oncology.

ECS Botanics has reported a return to profitability and positive cash flow in the first half of FY26, driven by a strategic shift to branded products and major infrastructure expansion.

De.mem Limited reported a 20% increase in revenue to $29.9 million for FY2025, alongside a reduced net loss and its first full-year positive adjusted EBITDA. The company also completed the acquisition of Core Chemicals, expanding its specialty chemicals footprint in the gold mining sector.

IMEXHS Limited delivered FY25 results at the top end of guidance, reporting a 10% revenue increase and a tripling of underlying EBITDA. The company’s software and radiology services both showed solid growth, setting the stage for an optimistic FY26 outlook.